Frontiers in Cardiovascular Medicine (Nov 2022)

Gallstone disease and the risk of cardiac mortality in patients with acute coronary syndrome

  • Wen Su,
  • Jie-Gao Zhu,
  • Wei-Ping Li,
  • Hui Chen,
  • Hong-Wei Li

DOI
https://doi.org/10.3389/fcvm.2022.1033959
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundGallstone disease is a common gastrointestinal disorder, which has previously been reported to be associated with the incidence of cardiovascular disease. We aimed to investigate the association between gallstone disease and long-term outcomes in patients with acute coronary syndrome (ACS).Materials and methodsA total of consecutive 13,975 ACS patients were included in this analysis. Gallstone disease in our study included both gallstones and cholecystectomy. The primary endpoint was cardiac mortality. The secondary outcome was all-cause mortality. Relative risks were estimated using Cox proportional hazards regression.ResultsDuring a median follow-up period of 2.96 years, 518 (4.2%) patients without gallstone disease and 62 (3.6%) patients in those with gallstone disease suffered cardiac death. After multivariable adjustment for established risk factors, subjects with gallstone disease had decreased risks of both cardiac mortality and all-cause mortality [hazard rate ratios (HR) = 0.72, 95% CI: 0.55–0.95 and HR = 0.75, 95% CI: 0.62–0.90, respectively]. In patients with performed cholecystectomy, the associations between gallstones and risks for cardiac mortality and all-cause mortality turned out to be non-significant. HRs varied across subgroups depending on the presence of selected established risk factors.ConclusionPresence of gallstone disease was associated with a significantly decreased risk of follow-up mortality in patients with ACS.

Keywords